APP and Alzheimer disease: The expression of miR-124 is down-regulated in patients with AD (Li et al., 1994; Lukiw, 2007), which could result in abnormal neuronal splicing of APP and, consequently, affect β-amyloid peptide production (Niwa et al., 2008; Smith et al., 2011).